Michele and Kent Stahl and their family have donated $1 million to the CMT Research Foundation (CMTRF). The donation…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Several novel mutations in aminoacyl-tRNA synthetase (ARS) genes were linked with Charcot-Marie-Tooth disease (CMT) in a recent study out…
The CMT Research Foundation has awarded nearly $100,000 to support a project that is seeking a better way to…
The Hereditary Neuropathy Foundation, known as HNF, is joining forces with Rarebase, a biotech company, on a project…
A new podcast called “CMT 4 Me,” launched by the patient-led Charcot-Marie-Tooth Association, aims to give a voice to…
Scientists have developed a new animal model of X-linked Charcot-Marie-Tooth disease type 6, or CMTX6, which is caused by…
InFlectis BioScience and the University of Chicago have entered into an agreement that grants InFlectis exclusive patent…
A new financial partnership between Pharnext and Alpha Blue Ocean will help support the Phase 3 clinical trial…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Augustine Therapeutics has received €1.2 million (about $1.4 million) in funding for a research project that will seek to…